AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • October 15th, 2015 • MHR Fund Management LLC • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “License Agreement”) is executed as of October 14, 2015 (but shall not have any force or effect until the License Agreement Effective Date as defined and as provided herein) by MHR Institutional Partners IIA LP, a Delaware limited partnership with offices at 40 West 57th Street, 24th Floor, New York, NY 10019 (“MHR”) and Novo Nordisk A/S, a Danish corporation with offices at Novo Allé, 2880 Bagsvaerd, Denmark (“Novo Nordisk”).
